BAYZED HEALTH (ASX: 02609) has announced the formal adoption of a new share incentive plan.
The company confirmed the plan was adopted on June 23, 2026, and will remain effective for a period of ten years from that date.
The scheme will be settled exclusively using existing shares, with no new shares to be issued.
The total number of shares available for awards under the plan is capped at 20 million.
A trustee will purchase shares from the secondary market in accordance with the plan rules and a trust deed, acting on the instructions of the board of directors, to fulfill the requirements for award exercises.
The primary objectives of the plan are twofold: firstly, to acknowledge the contributions of certain eligible participants and provide them with additional motivation to achieve performance goals, thereby working towards enhancing the company's value.
Secondly, the plan aims to attract suitable talent to foster the further development of the group.
Comments